Amaç: Ülkemizde majör ortopedik cerrahi (MOC) için farmakolojik profilaksi uygulanan hastalarda venöz tromboembolizm (VTE) risk faktörleri, kullanılan profilaksi yöntemleri ve klinik bulgu veren derin ven trombozu (DVT) ve pulmoner emboli (PE) sıklığı araştırıldı. Çalışma planı: Prospektif, çokmerkezli, açık, müdahalesiz bir gözlem çalışması planlanarak, 21 merkezden 899 hasta çalışmaya alındı. Olguların 316'sında (%35.2) total kalça protezi (TKP), 328'inde (%36.5) total diz protezi (TDP), 255'inde (%28.4) kalça kırığı (KK) cerrahisi uygulandı. Tüm hastalarda farmakolojik DVT profilaksisine başvuruldu. Sonuçlar: Olguların %73.2'sinde VTE risk faktörleri vardı. En sık görülen risk faktörleri obezite (%72) ve uzamış immobilizasyon (%36.3) idi. Profilaksi için olguların %91.1'inde düşük molekül ağırlıklı heparin, %8.9'unda fondaparinuks kullanıldı. Olguların 273'üne (%30.4) kısa dönem, 626'sına (%69.6) uzun dönem profilaksi uygulandı. Mekanik profilaksi 610 olguda (%67.9) elastik çorap ile, 67 olguda (%7.5) aralıklı hava basınç cihazı ile uygulandı. Üç aylık takip sonucunda sekiz olguda (%0.9) klinik bulgu veren DVT, dört olguda (%0.4) PE gelişti. Mortalite 10 olguda (%1.1) görüldü. Kanama komplikasyonu sekiz olguda (%0.9) majör, 40 olguda (%4.5) minör idi. Çıkarımlar: Etkin VTE profilaksi yapıldığında MOC'de klinik bulgu veren DVT ve PE oranları düşük olmaktadır.
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Total hip arthroplasty (THA), total knee athroplasty (TKA), and hip fracture (HF) surgery, which are referred to as major orthopaedic surgery (MOS), are common interventions in the practice of orthopaedics and traumatology. Venous thromboembolism (VTE) is one of the complications which occurss in patients undergoing such procedures. [1] Postoperative deep venous thrombosis (DVT) and pulmonary embolism (PE) can be fatal. The rate of DVT is 45% to 57% after THA, 41% to 85% after TKA, and 46% to 60% after HF surgery if prophylaxis is not used. [2, 3] As VTE prophylaxis, pharmacologic and mechanical prophylaxis methods can be used.
Although dextran, aspirin, and low-dose heparin were used in the past as pharmacologic methods, they are currently not preferred as first-line agents because of their controversial efficacies and the risks they bear. [3, 4] In the last three decades, introduction of low-molecular weight heparin and the subsequent use of synthetic pentasaccarides in recent years enabled prophylaxis with effective and safe agents. Early mobilization, compression stockings, and intermittent pneumatic compression (IPC) can be used for mechanical prophylaxis. The rate of DVTs and PEs are between 2% and24% following effective mechanical and pharmacologic thromboprophylaxis. [5, 6] The aim of the present study was to determine the VTE risk factors, prophylactic methods used, and the incidence of symptomatic DVTs and PEs in patients scheduled for MOS and who received pharmacologic prophylaxis in Turkey.
Patients and methods
A prospective, multicenter, open, noninterventional, observational study was planned and 21 centers in Turkey conducting more than 50 MOSs annually participated in the study. After obtaining approval from the local ethics committee of the coordinating center, a meeting with the investigators was conducted. A follow-up of 3 months was planned for each patient enrolled between March 2005 and March 2006, and the study commenced.
The inclusion criteria were determined as patients above 18 years of age who underwent MOS and were administered pharmacologic DVT prophylaxis. Exclusion criteria were not defined since the study was planned as a non-interventional, observational study. Five assessments were conducted for each patient: prior to the operation within the first 3 postoperative days, on discharge, on discontinuation of prophylaxis, and 3 months after surgery. Patients were assessed preoperatively in terms of sociodemographic characteristics, physical examinations, and VTE risk factors. After the surgery, operational data, vital findings, laboratory data, DVT prophylaxis and its complications, development of DVTs and PEs, and bleeding were evaluated. Nine hundred ninety-two patients from 21 centers were enrolled, each center contributing 4-50 patients. Ninety-three patients in whom the type of operation was not clearly defined or who were not assessed preoperatively were excluded from the study; therefore, 899 patients were evaluated.
Results
The MOSs performed and the distributions of the patients' mean age and gender are presented in Table  1 . Three hundred sixteen patients (35.2%) underwent THA, 328 patients (36.5%) underwent TKA, and 255 patients (28.4%) underwent surgery for a HF. The primary diagnosis was osteoarthritis in 67.1% and 88.9% of the patients who underwent total hip and knee arthroplasties, respectively. Of the proximal femur fractures, 92.7% were caused by trauma, and 4.4% also had hip osteoarthritis.
Risk factors of venous thromboembolism
VTE risk factors existed in 73.2% of the patients. The observed frequencies for these risk factors in pa- tients undergoing THA, TKA, and HF surgery were 60.4%, 75.3%, and 86.3%, respectively. The most commonly encountered risk factors were obesity, prolonged immobilization, smoking, and venous insufficiency. Most patients had more than one risk factor (Table 2) . Obesity was the most commonly observed risk factor in patients undergoing THA and TKA, and prolonged immobilization was most commonly observed in patients undergoing HF surgery.
When the threshold for obesity was accepted as 25 kg/m2, 225 (71.2%) of the patients undergoing THA, 278 (84.8%) of the patients undergoing TKA, and 144 (56.5%) of the patients undergoing HF surgery were obese. When immobilization > 72 hours following surgery was considered as prolonged immobilization, 80 patients (25.3%) in the THA group, 77 patients (23.5%) in the TKA group, and 169 patients (66.3%) in the HF group had prolonged immobilization ( Table  3) .
Four hundred eighty-two patients (53.6%) general, 298 patients (33.2%) had spinal anesthesia, and 129 patients (14.4%) had epidural anesthesia.
For pharmacologic VTE prophylaxis, lowmolecular-weight heparin (LMWH; enoxaparin, nadroparin, dalteparin, and tinzaparin) and fondaparinux were administered in 91.1% and 8.9% of the patients, respectively. As mechanical prophylaxis, compression stockings were used in 610 patients (67.9%), whereas IPC was used in only 67 patients (7.5%).
Prophylaxis was initiated in 449 patients (49.9%) before the surgery and in 450 patients (50.1%) after the surgery. Two hundred seventy-three patients (30.4%) were administered short-term prophylaxis and 626 patients (69.6%) were administered long-term prophylaxis; prophylaxis was terminated prematurely in 5.7% of the patients.
Eight patients (0.9%) developed DVTs and 4 patients (0.4%) developed PEs. Of the DVT cases, 6 in the TKA group and 2 in the HF group, 4 occurred within 10 days and the remaining 4 cases occurred after discharge. The diagnosis of DVT was based on a swollen thigh and limb. In three cases, the diagnosis was confirmed by Doppler ultrasonography. The risk factors for DVTs were obesity in three patients, obesity and prolonged immobilization in one patient, obesity and a history of a DVT in one patient, and prolonged immobilization in two patients. Obesity and prolonged immobilization were the most commonly encountered risk factors. Pharmacologic prophylaxis consisted of LMWH in seven patients and synthetic pentasaccaride in one patient who developed DVTs.
Two PEs occurred in the TKA group and two PEs occurred in the HF group. The diagnosis of PE was established by computerized tomography in three patients and by clinical findings in one patient. In all cases, PEs developed within the first 5 days and the patients had a positive response to treatment. Of the PE cases, one patient had obesity, one patient had prolonged immobilization and smoking, and one patient had a history of a malignancy. One patient did not have any risk factors for a VTE. Pharmacologic prophylaxis was administered to all the patients who developed PEs with LMWH.
Death occurred in 10 patients (1.1%; 2 patients in the TKA group and 8 patients in the HF group). Sudden death occurred in two cases; nine deaths occurred in the hospital and one death occurred at home. The causes of deaths were reported to be cardiac causes in six cases, renal failure in one case, and the cause of death was not determined in three cases. An autopsy was not performed in any of the cases.
The number of cases requiring blood transfusion during surgery was 487 (54.2%). Wound site haematomas developed in 5 cases (0.6%), two of which required re-operation. In addition, intracerebral haemorrhage was observed in 3 cases (0.3%), minor bleeding was observed in 40 cases (4.5%), and thrombocytopenia was observed in 1 case (0.1%).
Discussion
DVT and PE are clinically significant, and even fatal complications commonly occurring in patients undergoing elective THAs and TKAs and urgently performed cases with HFs. Taking preventive measures are essential. Although the importance of preventing DVTs is well-known by orthopaedic surgeons, standardized prophylaxis is still lacking. This prospective study is the first and largest study performed in Turkey on this topic.
The present study was carried out in 21 centers conducting > 50 MOSs annually. In most of these centers, the target number was reached; however, one center contributed only four cases. Thirteen centers reached the target of 50 cases and the other centers contributed 31 or more cases. It was realized that efficient monitoring by the coordinator center and the controller company were important factors in reaching the specified target.
VTE risk factors, originally described by Virchow in 1956 and which are valid today, include stasis, endothelial damage, and hypercoagubility. Advanced age in the majority of the cases undergoing MOS, obstructed circulation, and endothelial damage in the vessels caused by the positioning of the leg during the operation are major risk factors for the development of a DVT. According to Beksac et al. [6] , the risk of VTE is 11.7-fold higher in patients undergoing MOS. Therefore, studies of DVT prophylaxis are often focused on this group of patients [7] [8] [9] [10] . We also selected patients undergoing THA and TKA and those with HF as the study group.
The distribution of the 899 cases in the THA, TKA, and HF groups was comparable (35.2%, 36.5%, and 28.4%, respectively). The primary diagnosis was osteoarthritis in 67.1% and 88.9% of the patients in the THA and TKA groups, respectively; this finding is consistent with the literature. [11] When the VTE risk factors were evaluated in patients undergoing MOS, 73.2% of the patients had a risk factor, and the most commonly encountered risk factors were found as obesity, prolonged immobilization, smoking, and venous insufficiency. Smoking and venous insufficiency, which are considered minor risk factors for VTE [6, 12] , were found among the common risk factors in our study.
Obesity is a risk factor for VTE. Lowe et al. [12] reported that patients with a body mass index (BMI) > 30 kg/m2 had a 2.04-fold higher risk of DVT, whereas White et al. [13] reported that the risk is 1.8-fold higher in patients with a BMI > 25 kg/m2. Beksac et al. [6] reported that 379 of 1908 cases (19.8%) undergoing THA were obese; and 9 of 39 cases (23%) who developed DVTs and PEs were obese. In the present study, the rate of obesity was 71.2% and 84.8% in patients undergoing THAs and TKAs, respectively, and 56.5% in patients with HFs. Of 12 cases, who developed DVT and PE, 6 (50%) had obesity.
Immobilization is also an important risk factor. Heit et al. [14] demonstrated a 3.04-fold higher risk of DVTs in patients with paresis or paralysis. In another study, immobilization up to 14 days due to bed rest was associated with 5.6-fold higher risk of VTE, and patients confined to wheelchair or bed, depending on the duration, had 1.73 to 5.64-fold higher rates of DVTs [15] . In the present study, the mean age of patients in the HF group was 70.4 years; the rate of immobilization before and after the surgery was higher in this group (66.3%). Of 12 patients who developed DVTs and PEs, 5 (41.7%) had prolonged immobilization.
Varicose veins are known to be a risk factor for VTE. This risk is inversely related with varicose veins and age. The rate of VTE declines with increasing age. If varicose veins exist, the rate of DVT is 4.2-fold higher at 45 years of age, 1.9-fold higher at 60 years of age, and 0.9-fold higher at 70 years of age [6] . Heit et al. [14] reported smoking to be a minor risk factor for VTE due to its negative effect on the vascular endothelium. In the present study, the presence of varicose veins and smoking were common risk factors of VTE during the pre-operative evaluation; however, of the patients who developed VTEs, only 1 patient (8.3%) had these risk factors.
As a pharmacologic prophylaxis, LMWH and fondaparinux were administered in 91.1% and 8.9% of the patients, respectively. This prophylaxis was short-term (7-10 days) in 30.4% of the patients and long-term (21-35 days) in 69.6% of the patients. Planes et al. [16] indicated that long-term prophylaxis is required in patients undergoing THAs. Patients with HFs were reported to have a lower rate of DVTs with long-term prophylaxis due to their old age and late mobilization. [2, 5, 10, 13] Based on the guidelines of the American College of Chest Physicians (ACCP) [2] and the European consensus statement (ICS) [17] , LMWH, fondaparinux, and coumadin are recommended for VTE prophylaxis in THAs and TKAs and in patients with HFs.
[2] The pharmacologic prophylaxis method used in this study was in accordance with the international guidelines.
Among mechanical prophylaxis methods to prevent VTEs, compression stockings and IPC devices are adjuvant methods according to the guidelines of the ACCP and should not be used as a single method. [2] In the present study, these methods were administered as an adjuvant to pharmacologic prophylaxis. Compression stockings were used in 67.9% of the patients and an IPC was used in 7.5% of the patients. The reason why compression stockings were not used in all patients was the higher number of obese patients, who are not suitable for compression stockings. Low rates of IPC use could be attributed to the absence of IPC devices in a center, refusal of administration by the patients, and physician discretion. In patients receiving enoxaparin after THA, the rate of DVT determined by venography or ultrasonography has been reported to range between 2.8% and 20%. [5, 6, 18, 19] This rate is between 2.1% and 27.8% in patients undergoing TKA [5, 20] who were administered LMWH and between 19.1 and 30.4% in patients with HFs who were administered LMWH. [8, 10, 20] The patients undergoing THA in this study did not develop symptomatic DVTs; however, 1.8% of the patients undergoing TKAs and 0.8% of the patients with HFs developed DVTs. Absence of DVTs and PEs in patients undergoing THAs is thought to be related to the inability to establish a clinical diagnosis. The patients were followed clinically without performing routine venography or ultrasonography. The rate of symptomatic DVT is approximately 1% to2% in MOSs. [13] The rate in the current study was 0.9% when all of our cases were considered.
In patients receiving prophylaxis with vitamin K antagonists or standard heparin, monitoring for the risk of major bleeding is mandatory. However, monitoring is not necessary when LMWH or fondaparinux is administered. The rate of wound site or distant major bleeding following MOS is 1% to 3%. [3, 21, 22] In the current study, 5 cases (0.6%) developed haematomas and 3 cases (0.3%) developed intracerebral haemorrhage. Re-operation was required in 2 cases (0.2%) due to wound site haematomas. The total rate of major bleeding in our cases was 0.9%. The rate of minor bleeding is reported to be 2% to 4% in the literature. [3, 21] In the present study, the rate of minor bleeding was 4.5%, which is consistent with the literature.
Thrombocytopenia is observed with a rate of 2% to 4% in patients receiving long-term standard heparin, while the rate is < 2% in patients receiving LMWH. [3] In the present study, only 1 patient (0.1%) with thrombocytopenia was observed. The lower than expected rate of thrombocytopenia was attributed to an inability to document the subclinical cases.
In THA procedures using VTE prophylaxis, the inhospital mortality rate is 0.09% [21] and the mortality rate within 90 days is 0.22% to 0.34%. [5, 23] This rate is 0.1% to 0.15% in TKA procedures. [20, 23] The overall mortality rate in MOS is 0.2% to 5%. [2, 11] In the present study, the mortality rate was 0% in THAs, 0.6% in TKAs, and 3.1% in patients with HFs, and the overall mortality was 1.1%. The higher mortality rate observed in patients with HFs compared to elective THAs and TKAs is consistent with the literature.
As a result of this study, it was determined that in Turkey the most common risk factors for DVTs and PEs in patients undergoing MOSs are obesity and prolonged immobilization. Pharmacologic prophylaxis is in accordance with the literature, and LMWH is the most commonly used pharmacologic agent for VTE prophylaxis. Use of an IPC device as an adjuvant mechanical prophylaxis method was lower than reported in the literature. The rate of symptomatic DVTs and PEs following MOS was 1.3% and the rate of major bleeding was 0.9%.
